TrialHaematologica2021

Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas.

Jakub Svoboda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.